FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly ophthalmology and can be used for treating optic nerve atrophy in infants. The method involves the subcutaneous temporal introduction of the peptide bioregulator Retinalamine from both sides at depth 2.5 mg within a projection of a temporal muscle, for preparing a solution for injection, the content of a Retinalamine bottle 5 mg is pre-dissolved in 0.5% Novocaine 1.0 ml; the therapeutic course includes 5 daily procedures; the number of courses is 3 and more every 6 months.
EFFECT: invention allows improving the generation and conduction of a visual nervous impulse that leads to recovering receptive fields of the visual nervous apparatus and causes maintaining or increasing visual acuity.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DISEASES OF OPTIC NERVE AND RETINA | 2008 |
|
RU2373904C1 |
| METHOD OF TREATING VISUAL NERVE AND RETINAL DISEASES | 2010 |
|
RU2447864C1 |
| METHOD FOR TREATING DYSTROPHIC DISEASES OF EYES | 2000 |
|
RU2195297C2 |
| METHOD OF TREATING VISUAL PATHWAY DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS | 2011 |
|
RU2479328C2 |
| METHOD OF TREATING OPTIC ATROPHY IN CHILDREN OF AGE FROM 1 TO 6 MONTHS | 2009 |
|
RU2402363C1 |
| METHOD OF DETERMINATION OF INDICATIONS FOR TREATMENT OF AMBLIOPY USING THE NEUROPEPTIDE PREPARATION | 2017 |
|
RU2647324C1 |
| METHOD FOR TREATING DIABETIC RETINOPATHY | 1999 |
|
RU2157154C1 |
| METHOD OF TREATING ELDERLY AND SENILE GLAUCOMA OPTIC NEUROPATHY | 2009 |
|
RU2411033C1 |
| METHOD OF TREATING OPTIC NERVE ATROPHY OF VASCULAR GENESIS | 2011 |
|
RU2452436C1 |
| METHOD FOR INCREASING OPTIC FUNCTIONS IN CHILDREN WITH INBORN OPTIC NYSTAGMUS | 2005 |
|
RU2295280C1 |
